Nature's Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq
Nature's Miracle Holding (NASDAQ: NMHI), a vertical farming technology company, announced receiving a delisting notification from Nasdaq on January 13, 2025. The delisting is due to the company's failure to meet the minimum shareholder's equity requirement under Nasdaq Listing Rule 5550(b)(1).
Trading of NMHI's common stock and warrants will be suspended on Nasdaq effective January 15, 2025. The company has 15 days to appeal the decision to the Nasdaq Listing and Hearing Review Council, which can also independently review the decision within 45 calendar days.
Following the Nasdaq suspension, NMHI's common stock and warrants are expected to be quoted on the OTC Pink market under the symbols 'NMHI' and 'NMHW' respectively.
Nature's Miracle Holding (NASDAQ: NMHI), un'azienda di tecnologia per l'agricoltura verticale, ha annunciato di aver ricevuto una notifica di esclusione dalla Nasdaq il 13 gennaio 2025. L'esclusione è dovuta al mancato rispetto da parte dell'azienda del requisito minimo di patrimonio netto degli azionisti ai sensi della Regola di Quotazione 5550(b)(1) di Nasdaq.
Le contrattazioni delle azioni ordinarie di NMHI e dei warrant saranno sospese su Nasdaq a partire dal 15 gennaio 2025. L'azienda ha 15 giorni per presentare ricorso al Nasdaq Listing and Hearing Review Council, che può anche riesaminare indipendentemente la decisione entro 45 giorni di calendario.
Dopo la sospensione da parte di Nasdaq, si prevede che le azioni ordinarie di NMHI e i warrant vengano quotati sul mercato OTC Pink con i simboli 'NMHI' e 'NMHW' rispettivamente.
Nature's Miracle Holding (NASDAQ: NMHI), una empresa de tecnología de agricultura vertical, anunció haber recibido una notificación de exclusión de Nasdaq el 13 de enero de 2025. La exclusión se debe al incumplimiento de la empresa del requisito mínimo de capital de los accionistas según la Regla de Cotización 5550(b)(1) de Nasdaq.
La negociación de las acciones ordinarias de NMHI y los warrants se suspenderá en Nasdaq a partir del 15 de enero de 2025. La empresa tiene 15 días para apelar la decisión ante el Nasdaq Listing and Hearing Review Council, que también puede revisar la decisión de manera independiente dentro de los 45 días naturales siguientes.
Tras la suspensión de Nasdaq, se espera que las acciones ordinarias de NMHI y los warrants sean cotizados en el mercado OTC Pink bajo los símbolos 'NMHI' y 'NMHW' respectivamente.
Nature's Miracle Holding (NASDAQ: NMHI), 수직 농업 기술 회사가 2025년 1월 13일 나스닥으로부터 상장 폐지 통보를 받았다고 발표했습니다. 상장 폐지는 나스닥 상장 규칙 5550(b)(1)에 따른 최소 주주 자본 요건을 충족하지 못했기 때문입니다.
NMHI의 보통주와 워런트의 거래는 2025년 1월 15일부터 나스닥에서 중단됩니다. 이 회사는 나스닥 상장 및 청문회 검토 위원회에 결정에 항소할 수 있는 15일이 있으며, 위원회는 45일 이내에 결정에 대한 독립적인 검토를 진행할 수도 있습니다.
나스닥의 거래 중단 이후, NMHI의 보통주와 워런트는 각각 'NMHI' 및 'NMHW' 기호로 OTC Pink 시장에 상장될 예정입니다.
Nature's Miracle Holding (NASDAQ: NMHI), une entreprise de technologie de culture verticale, a annoncé avoir reçu une notification de radiation de la Nasdaq le 13 janvier 2025. La radiation est due à l'incapacité de l'entreprise à répondre à l'exigence minimale de capitaux propres des actionnaires conformément à la règle de cotation 5550(b)(1) de la Nasdaq.
La négociation des actions ordinaires de NMHI et des bons de souscription sera suspendue sur la Nasdaq à compter du 15 janvier 2025. L'entreprise a 15 jours pour faire appel de la décision auprès du Nasdaq Listing and Hearing Review Council, qui peut également revoir indépendamment la décision dans les 45 jours suivant le calendrier.
Suite à la suspension par la Nasdaq, les actions ordinaires de NMHI et les bons de souscription devraient être cotés sur le marché OTC Pink sous les symboles 'NMHI' et 'NMHW' respectivement.
Nature's Miracle Holding (NASDAQ: NMHI), ein Unternehmen für vertikale Landwirtschaftstechnologie, gab bekannt, am 13. Januar 2025 eine Abberufungsbenachrichtigung von der Nasdaq erhalten zu haben. Die Abberufung erfolgt aufgrund der Nichteinhaltung der Mindestanforderungen an das Eigenkapital der Aktionäre gemäß der Nasdaq-Listing-Regel 5550(b)(1).
Der Handel mit den Stammaktien von NMHI und den Warrants wird ab dem 15. Januar 2025 an der Nasdaq ausgesetzt. Das Unternehmen hat 15 Tage Zeit, um gegen die Entscheidung beim Nasdaq-Listing- und Hearing-Review-Rat Berufung einzulegen, der die Entscheidung auch innerhalb von 45 Kalendertagen unabhängig überprüfen kann.
Nach der Aussetzung durch die Nasdaq wird erwartet, dass die Stammaktien von NMHI und die Warrants unter den Symbolen 'NMHI' und 'NMHW' jeweils im OTC Pink Markt notiert werden.
- None.
- Delisting from Nasdaq due to non-compliance with minimum shareholder's equity requirement
- Downgrade to OTC Pink market trading, potentially reducing stock visibility and liquidity
- Loss of Nasdaq listing status may impact investor confidence and access to capital markets
Insights
The delisting notification represents a severe blow to Nature's Miracle's market position and investor accessibility. Moving from Nasdaq to OTC Pink marks a significant downgrade in trading venue, which typically results in reduced liquidity, decreased institutional investor interest and more challenging capital raising conditions. The failure to maintain the minimum shareholder's equity requirement suggests serious underlying financial health issues.
The transition to OTC Pink trading usually leads to:
- Reduced trading volume and wider bid-ask spreads
- access to institutional capital
- Decreased analyst coverage
- Higher cost of capital for future fundraising
While the company has appeal options, historical patterns show that successful appeals in cases of equity requirement violations are rare unless accompanied by substantial capital infusion or strategic restructuring. The
The delisting process reveals critical regulatory compliance failures that extend beyond mere technical violations. The company's inability to maintain minimum shareholder's equity under Rule 5550(b)(1) indicates fundamental governance concerns. While the 15-day appeal window provides a temporary lifeline, the transition to OTC Pink trading appears increasingly likely.
Key legal implications include:
- Increased vulnerability to shareholder litigation
- Enhanced reporting burdens to maintain market confidence
- Potential breach of existing financial covenants
The company's statement about 'considering' an appeal, rather than definitively pursuing one, suggests confidence in meeting compliance requirements. This regulatory setback could trigger cascading effects on existing contracts and financing agreements that may contain Nasdaq listing requirements as covenants.
The Company has 15 days after the date it received notice of the Panel's decision to request that the Nasdaq Listing and Hearing Review Council (the "Council") review the Hearing Panel's decision, or the Council may, on its own motion, determine to review the Hearing Panel's decision within 45 calendar days of the issuance of the decision.
The Company is considering to appeal the decision.
Upon suspension of the trading of its common stock on Nasdaq, the Company expects that its common stock and warrants will be quoted under its existing symbol "NMHI" and "NMHW" respectively, on the OTC Pink .
About Nature's Miracle Holding Inc.
Nature's Miracle (www.Nature-Miracle.com) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture ("CEA") industry around the world. The company has recently launched EV and bitcoin business, all energy dependent as CEA.
Forward-Looking Statements
The information in this press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intends," "may," "will," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature's Miracle's joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature's Miracle's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature's Miracle's ability to develop and launch new products and services; Nature's Miracle's ability to successfully and efficiently integrate future expansion plans and opportunities; Nature's Miracle's ability to grow its business in a cost-effective manner; Nature's Miracle's product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature's Miracle's business model; developments and projections relating to Nature's Miracle's competitors and industry; and Nature's Miracle's approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company's shares on Nasdaq; changes in applicable laws or regulations; the effects of the coronavirus (COVID-19) and any future outbreaks on Nature's Miracle's business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature's Miracle's operates; the risk that Nature's Miracle's and its current and future collaborators are unable to successfully develop and commercialize Nature's Miracle's products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature's Miracle's is unable to secure or protect its intellectual property; the possibility that Nature's Miracle's may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature's Miracle's filings from time to time with the SEC.
For more information, please contact:
Nature's Miracle Holding, Inc.
Investor Relations Department
ir@nature-miracle.com
Ascent Investors Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
View original content:https://www.prnewswire.com/news-releases/natures-miracle-holding-inc-announces-receipt-of-delisting-notification-from-nasdaq-302351049.html
SOURCE Nature's Miracle Holding Inc.
FAQ
Why is Nature's Miracle (NMHI) being delisted from Nasdaq?
When will NMHI stock be suspended from trading on Nasdaq?
What happens to NMHI shares after Nasdaq delisting?
Can Nature's Miracle appeal the Nasdaq delisting decision?
